Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Gynecology

  Free Subscription


Articles published in Int J Oncol

Retrieve available abstracts of 26 articles:
HTML format



Single Articles


    March 2024
  1. GRUNT TW, Wagner R, Ries A, Berghoff AS, et al
    Targeting endogenous fatty acid synthesis stimulates the migration of ovarian cancer cells to adipocytes and promotes the transport of fatty acids from adipocytes to cancer cells.
    Int J Oncol. 2024;64:24.
    PubMed     Abstract available


  2. GENG D, Zhou Y, Wang M
    Advances in the role of GPX3 in ovarian cancer (Review).
    Int J Oncol. 2024;64:31.
    PubMed     Abstract available


  3. INOUE F, Sone K, Kumegawa K, Hachijo R, et al
    Inhibition of protein arginine methyltransferase 6 activates interferon signaling and induces the apoptosis of endometrial cancer cells via histone modification.
    Int J Oncol. 2024;64:32.
    PubMed     Abstract available


    January 2024
  4. LIU Y, Yang Y, Wang X, Yin S, et al
    Function of microRNA?124 in the pathogenesis of cancer (Review).
    Int J Oncol. 2024;64:6.
    PubMed     Abstract available


    December 2023
  5. QI Y, Ma N, Zhang J
    Tripartite motif containing 33 demonstrated anticancer effect by degrading c?Myc: Limitation of glutamine metabolism and proliferation in endometrial carcinoma cells.
    Int J Oncol. 2023;63:133.
    PubMed     Abstract available


  6. LIANG T, Lu T, Jia W, Li R, et al
    Knockdown of lncRNA MALAT1 induces pyroptosis by regulating the miR?124/SIRT1 axis in cervical cancer cells.
    Int J Oncol. 2023;63:138.
    PubMed     Abstract available


    November 2023
  7. DENG F, Fu M, Zhao C, Lei J, et al
    Calcium signals and potential therapy targets in ovarian cancer (Review).
    Int J Oncol. 2023;63:125.
    PubMed     Abstract available


    October 2023
  8. YUAN J, Guan W, Li X, Wang F, et al
    RBM15‑mediating MDR1 mRNA m(6)A methylation regulated by the TGF‑beta signaling pathway in paclitaxel‑resistant ovarian cancer.
    Int J Oncol. 2023;63:112.
    PubMed     Abstract available


    September 2023
  9. O'DONNELL J, Zhao Z, Buckingham L, Hao T, et al
    Ipatasertib exhibits anti‑tumorigenic effects and enhances sensitivity to paclitaxel in endometrial cancer in vitro and in vivo.
    Int J Oncol. 2023;63:103.
    PubMed     Abstract available


    August 2023
  10. ZHAI L, Yang X, Dong J, Qian L, et al
    O‑GlcNAcylation mediates endometrial cancer progression by regulating the Hippo‑YAP pathway.
    Int J Oncol. 2023;63:90.
    PubMed     Abstract available


    May 2023
  11. CHEN Q, Shen S, Lv N, Tong J, et al
    Role of microRNAs in glycolysis in gynecological tumors (Review).
    Int J Oncol. 2023;62:63.
    PubMed     Abstract available


    December 2022
  12. KARIN-KUJUNDZIC V, Covarrubias-Pinto A, Skrtic A, Vranic S, et al
    New insight into the role of PTCH1 protein in serous ovarian carcinomas.
    Int J Oncol. 2022;61.
    PubMed     Abstract available


  13. SHEN S, Guo J, Lv N, Chen Q, et al
    RNA m6A methylation regulators in endometrial cancer (Review).
    Int J Oncol. 2022;61.
    PubMed     Abstract available


    November 2022
  14. ENDO Y, Sugimoto K, Kobayashi M, Kobayashi Y, et al
    Claudin9 is a novel prognostic biomarker for endometrial cancer.
    Int J Oncol. 2022;61.
    PubMed     Abstract available


    October 2022
  15. WANG Y, Han A, Chen E, Singh RK, et al
    [Corrigendum] The cranberry flavonoids PAC DP9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells.
    Int J Oncol. 2022;61.
    PubMed     Abstract available


  16. LI R, Wang Y, Xu Y, He X, et al
    [Retracted] Silencing the long noncoding RNA, TINCR, a molecular sponge of miR335, inhibits the malignant phenotype of epithelial ovarian cancer via FGF2 suppression.
    Int J Oncol. 2022;61.
    PubMed     Abstract available


  17. BJERSAND K, Blom K, Poromaa IS, Stalberg K, et al
    Ex vivo assessment of cancer drug sensitivity in epithelial ovarian cancer and its association with histopathological type, treatment history and clinical outcome.
    Int J Oncol. 2022;61.
    PubMed     Abstract available


  18. KIM SH, Baek KH
    Ovarian tumor deubiquitinase 6A regulates cell proliferation via deubiquitination of nucleolin and caspase7.
    Int J Oncol. 2022;61.
    PubMed     Abstract available


    July 2022
  19. XU L, Li J, Tursun M, Hai Y, et al
    Receptor for activated C kinase 1 promotes cervical cancer lymph node metastasis via the glycolysisdependent AKT/mTOR signaling.
    Int J Oncol. 2022;61.
    PubMed     Abstract available


  20. FEDIER A, Maggi N, Tozzi A, Disler M, et al
    Exposure to escalating olaparib does not induce acquired resistance to PARPi and to other chemotherapeutic compounds in ovarian cancer cell lines.
    Int J Oncol. 2022;61.
    PubMed     Abstract available


    May 2022
  21. ZHANG R, Roque DM, Reader J, Lin J, et al
    Combined inhibition of IL6 and IL8 pathways suppresses ovarian cancer cell viability and migration and tumor growth.
    Int J Oncol. 2022;60.
    PubMed     Abstract available


  22. LAVORO A, Scalisi A, Candido S, Zanghi GN, et al
    Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families?
    Int J Oncol. 2022;60.
    PubMed     Abstract available


    March 2022
  23. LI L, Yu J, Duan Z, Dang HX, et al
    [Corrigendum] The effect of NFATc1 on vascular generation and the possible underlying mechanism in epithelial ovarian carcinoma.
    Int J Oncol. 2022;60.
    PubMed     Abstract available


  24. SINGH T, Neal A, Dibernardo G, Raheseparian N, et al
    Efficacy of birinapant in combination with carboplatin in targeting platinumresistant epithelial ovarian cancers.
    Int J Oncol. 2022;60.
    PubMed     Abstract available


    January 2022
  25. FAN LX, Tao L, Lai YC, Cai SY, et al
    Cx32 promotes autophagy and produces resistance to SNinduced apoptosis via activation of AMPK signalling in cervical cancer.
    Int J Oncol. 2022;60.
    PubMed     Abstract available


    July 2021
  26. FALZONE L, Scandurra G, Lombardo V, Gattuso G, et al
    A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer (Review).
    Int J Oncol. 2021;59.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.